# FDA recall D-0010-2019

> **Pfizer Inc.** · Class II · drug recall initiated 2018-09-20.

## Product

Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: Greenstone LLC. Peapack, NJ 07977 --- NDC 59762-0541-2

## Reason for recall

CGMP Deviations; rejected product was used to manufacture final bulk lot

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0010-2019
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-09-20
- **Report date:** 2018-10-17
- **Termination date:** 2020-05-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0010-2019

## Citation

> AI Analytics. FDA recall D-0010-2019. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-0010-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*